Open Access
MATEC Web of Conferences
Volume 60, 2016
2016 3rd International Conference on Chemical and Biological Sciences
Article Number 03002
Number of page(s) 5
Section Applied Chemistry
Published online 08 June 2016
  1. María L. Cuestas & Verónica L. Mathet. Drug delivery systems and liver targeting for improved pharmacotherapy of the Hepatitis B virus (HBV) infection. Pharm Res, 27, 1184–1202 (2010) [CrossRef] [Google Scholar]
  2. Su-zhen Jiang, Jia-jia Zheng. Hepatitis B Virus S Promoter Deletionin Hepatocellular Carcinoma. Infection Inte national, 1, 14-23 (2012) [Google Scholar]
  3. Hepatitis B. World Health Organization. World Health Org. 204 (2012) [Google Scholar]
  4. Park NH, Song IH. Chronic hepatitis B in hepatocarcinogenesis.Pos. Med J, 82(970), 507–515.(2006) [Google Scholar]
  5. Westland C, Delandy W. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil.Gas, 125(1), 107-116 (2003) [CrossRef] [Google Scholar]
  6. Wright TL.Introduction to chronic hepatitis B infection.Am J Gastl, 101, 1-6 (2006) [CrossRef] [Google Scholar]
  7. Ceen-Ming Tang, Tung On Yau. Management of chronic hepatitis B infection: Currenttreatment guidelines, challenges, and new developmentsWorld J Gastroenterol, 20(20), 6262-6278 (2014) [CrossRef] [Google Scholar]
  8. Han YX, Xue R,Zhao W. Antiviral therapertic efficacy of foscamet inhepatitis B virus infection. Antiv Res, 68(3), 147-153 (2005) [CrossRef] [Google Scholar]
  9. Shin MS, Kang EH. A flavonoid from medicinal plants blocks hepatitis Bvirus-e antigen secretion in HBV-infected hepatocytes. Antiv Res, 67(3), 163–168 (2005) [CrossRef] [Google Scholar]
  10. Zembower DE, Lin YM. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiv Res, 39(2),81-88 (1998) [CrossRef] [Google Scholar]
  11. Zhou Z,Zhang Y,Ding XR. Protocatechuic aldehyde inhibits hepatitis Bvirus replication both in vitro and in vivo. Antiv Res, 74(1), 59–64 (2007) [CrossRef] [Google Scholar]
  12. Addison WR, Wong WW. A quantitative competitive PCR assay for thecovalently closed circular form of the duck hepatitis B virus. Antiv Res, 48(l), 27-37 (2000) [CrossRef] [Google Scholar]
  13. Le Guerhier F, Thermet A. Antiviral effect of adefovir in combination with aDNA vaccine in the duck hepatitis B virus infection model.J. Hepa, 38(3), 328-334 (2003) [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.